Elizabeth Halton

Statistics

Publications

Citations

7.2K

H-Index

Active since

2011

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Milan

Fondazione IRCCS Istituto Nazionale dei Tumori

Kettering University

Elizabeth Halton is an author at Memorial Sloan Kettering Cancer Center specializing in immunotherapy, chimeric antigen receptor t-cell therapy, and oncology.

Publications per year

2011–2025

Publications

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Isabelle Rivière, Xiuyan Wang et al. · Science Translational Medicine · 2014 · 2.5K citations · Full text

Medicine, Hematology, Oncology +17

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

Medicine, Immunology, Oncology +11

Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia

Bianca Santomasso, Jae H. Park, Darin Salloum et al. · Cancer Discovery · 2018 · 924 citations · Full text

Life Sciences, Immunology, Neurology +17

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière et al. · Cancer Discovery · 2021 · 560 citations · Full text

Medicine, Oncology, Pharmacology +17

Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy

Melody Smith, Anqi Dai, Guido Ghilardi et al. · Nature Medicine · 2022 · 309 citations · Full text

Life Sciences, Immunology, Microbiology +14

1–5 of 31